D-Glutamic acid

D-Glutamic acid is the D-stereoisomer of the canonical amino acid glutamate, featuring a chiral alpha carbon bearing an amino group and a carboxylic acid, plus a second side-chain carboxylic acid that enables strong hydrogen-bonding and salt formation. The molecule exists as a zwitterionic species under many conditions, and its two carboxyl groups display distinct reactivity profiles in coupling, protection, and activation chemistry. The side-chain carboxylate can be selectively addressed through orthogonal protection strategies, while the amino functionality can be converted into amide, urea, or protected amine derivatives for peptide building block preparation. As a chiral amino acid starting material, D-Glutamic acid serves as a stereochemically defined intermediate for amino acid derivatization, racemate-avoidant synthesis, and downstream construction of D-configured peptide motifs.

1. Peptide Synthesis

D-Glutamic acid is applied in peptide synthesis workflows where D-configured glutamate residues are required for stereodefined peptide backbones and peptidomimetic scaffolds. The amino group and the two carboxyl functionalities enable controlled formation of peptide bonds after appropriate activation and protection, with orthogonal masking strategies supporting selective coupling at the alpha-carboxyl position while preserving the side-chain carboxyl for later functionalization. The stereocenter at the alpha carbon allows incorporation of D-glutamate into linear peptides, cyclic peptides, and protected peptide fragments using standard amino acid coupling chemistries. Downstream products include D-glutamate-containing peptide building blocks, protected peptide intermediates, and stereochemically controlled analog libraries for peptide science and structure-based studies.

2. Side-Chain Functionalization

D-Glutamic acid is used in chemical biology and synthetic organic chemistry for side-chain carboxyl derivatization, enabling access to glutamate-based functional handles for further transformation. The side-chain carboxylic acid can be converted into activated esters, amides, or other carboxyl derivatives, supporting attachment of linkers, affinity tags, or reactive groups while maintaining the D-configuration at the alpha stereocenter. Protection and deprotection logic can be designed so that the alpha amino and alpha carboxyl participate in peptide coupling or amide formation, whereas the side-chain carboxyl is reserved for post-coupling modification. Resulting downstream materials include functionalized D-glutamate conjugates, carboxylate-bearing intermediates for scaffold diversification, and stereochemically defined ligands used in biomolecular interaction studies.

3. Chiral Building Blocks

D-Glutamic acid functions as a chiral amino acid intermediate for stereoselective synthesis of D-configured derivatives used in medicinal chemistry research and fine chemical manufacturing. The presence of two carboxyl groups and one amino group allows conversion into protected amino acid derivatives such as N-protected forms and selective ester or acid-protecting variants that support sequential chemistry without racemization. The D-stereochemical integrity is maintained through protection-group selection and orthogonal activation strategies, enabling preparation of chiral intermediates for incorporation into larger molecules, including peptidomimetics and nonproteinogenic analogs. Downstream utility includes chiral intermediate preparation for process chemistry routes, stereochemically defined reagents for library synthesis, and D-glutamate-derived fragments used to build complex functional scaffolds.

4. Bioconjugation Chemistry

D-Glutamic acid is suitable for bioconjugation chemistry where glutamate-derived carboxyl functionality supports linker installation and controlled attachment to biomolecules. The amino acid's side-chain carboxyl can be transformed into conjugation-ready moieties, while the alpha amino and alpha carboxyl can be managed through protection strategies to generate defined mono- or bifunctional conjugation intermediates. D-configuration can be leveraged to tune stability and resistance to proteolytic processing in peptide-like conjugates used for biochemical labeling and molecular recognition experiments. Downstream products include D-glutamate-based linker units, biomolecule conjugation intermediates, and analytical or affinity reagents that incorporate stereochemically defined glutamate motifs.

5. Pharmaceutical Intermediate Preparation

D-Glutamic acid is used as an amino acid-based intermediate in pharmaceutical intermediate preparation and specialty chemical production where D-configured glutamate motifs appear in peptide-like drug candidates and peptidomimetic designs. The dual carboxyl functionality supports conversion into protected acid/ester forms that can be carried through multi-step synthesis and then unmasked for final coupling or salt formation. The amino group can be protected to enable selective activation of the desired carboxyl site, supporting controlled assembly of amide linkages and incorporation into larger molecular frameworks. Downstream relevance includes manufacture of protected D-glutamate derivatives, process-compatible intermediates for fragment assembly, and stereochemically defined building blocks for industrial fine chemical synthesis and applied research pipelines.

1. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore